Collaborative Drug Discovery (CDD) has completed the integration of a molecular biology tool into its informatics platforms, CDD Vault, the company has announced.
CDD has integrated the SnapGene Server into CDD Vault, enabling users to visualise and share plasmid information such as maps and sequences.
SnapGene is a molecular biology tool used by scientists globally. SnapGene Server enables plasmid map and sequence output in a web browser, plus the ability to annotate and obtain a list of primers, restriction sites, and other common features.
CDD Vault is a secure, hosted platform where research teams can organise, query, and share biological and chemical entities and associated data.
CDD states that the integration of SnapGene builds upon recent capabilities such as Activity & Registration, ELN, Inventory, and Visualisation to allow for a better user experience.
“Customers expect the best of breed technologies to work seamlessly with each other. Scientists throughout the world can now access leading technologies for Biologics Registration, Analyses, and secure Collaboration. The SnapGene partnership is one of the ways we made CDD Vault the ideal informatics system for Biologics R&D,” said Dr Barry Bunin, CEO of CDD. “It highlights CDD’s strength collaborating with other leading organisations. It fits, given Collaborative is right in the name of our company.”